We are the leading Spanish company marketing R&D products nationally and internationally.

Almirall in figures

Our figures are the result of combining an outstanding business structure, an excellent team of professionals, sound values, an international perspective and substantial investment in R&D, all resulting in a high quality product portfolio which allows us to offer the best therapeutic solutions for people all over the world.

Net sales Net sales

General data 2009

Net sales (*)

(in millions of euros)
Spanish market
536
Foreign market
389,5
Total
925,5
(*) Local sales, Almirall and partners.
Market share in Spain
5,4
Percentage of proprietary products over total income
aprox 45%

Own R&D products

(geographical location)

  • Aceclofenac: Europe, Asia-Pacific, Africa, Middle East, Central America and South America.
  • Almagate: Europe, Asia-Pacific and Central America.
  • Almotriptan: Europe and North America.
  • Cinitrapide: Europe and Central America.
  • Clebopride: Europe and Asia-Pacific.
  • Ebastine: Europe,Africa, Asia-Pacific, Middle East, Central America and South America.
  • Piketoprofen: Europe.

Resources in R&D

  • Around 15% over net sales
  • Around 15% of the workforce

Ten best-selling products

63% of sales in 2009 corresponded to the company's ten best-selling products, with three of them being Almirall R&D products:

Active Ingredient Therapeutic Area Pathology
1 Ebastine * Respiratory Allergy
2 Atorvastatin Cardiovascular Cholesterol
3 Escitalopram Central nervous system Depression
4 Salmeterol + fluticasone Respiratory Asthma COPD
5 Almotriptan * Central nervous system Migraine
6 Candesartan cilexetil Cardiovascular Hypertension
7 Aceclofenac * Osteomuscular Pain
8 Lansoprazol Digestive Ulcers
9 Venlafaxine Central nervous system Depression
10 Diclofenac sodium + hialuronic acid Dermatology Actinic keratoses

(*) Almirall R&D products

Workforce 2010 (estimated)

(includes full time equivalence)
Spain
1.800
International
1.300
Total
3.100
Global R&D
550
R&D Sant Feliu
Almost 350

Work centres

Headquarters

Barcelona

R&D

  • 3 R&D centres: Sant Feliu (Barcelona - Spain), Bad Homburg (Frankfurt - Germany) and Reinbek (Germany).
  • 2 Units: Chemical Synthesis in Sant Just Desvern and Active Ingredient Scale-up Unit in Sant Andreu de la Barca (Barcelona - Spain).

Production

5 centres:

  • 3 pharmaceutical plants in Sant Andreu de la Barca, Sant Just Desvern (Barcelona - Spain) and Reinbek (Germany).
  • 2 chemical plants in Sant Andreu de la Barca and Sant Celoni (Barcelona - Spain).